Emily Leven

2.9k total citations
16 papers, 395 citations indexed

About

Emily Leven is a scholar working on Hematology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Emily Leven has authored 16 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Emily Leven's work include Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Blood groups and transfusion (3 papers). Emily Leven is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Blood groups and transfusion (3 papers). Emily Leven collaborates with scholars based in United States, Israel and Denmark. Emily Leven's co-authors include James B. Bussel, Mayce Mansour, Ania Wajnberg, Damodara Rao Mendu, Kimberly Muellers, Kimberly Stone, Loan Hsieh, Diane J. Nugent, Kavitha Ramaswamy and Anja J. Gerrits and has published in prestigious journals such as Blood, The Journal of Pediatrics and Journal of General Internal Medicine.

In The Last Decade

Emily Leven

15 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Leven United States	10	153	129	69	54	48	16	395
Erik H Vogelzang Netherlands	8	109 0.7×	52 0.4×	110 1.6×	14 0.3×	44 0.9×	20	338
Femke Hooijberg Netherlands	8	116 0.8×	49 0.4×	94 1.4×	13 0.2×	26 0.5×	22	323
Padmanabha Shenoy India	9	122 0.8×	55 0.4×	98 1.4×	78 1.4×	15 0.3×	42	472
Erol Demir Türkiye	12	131 0.9×	30 0.2×	63 0.9×	22 0.4×	12 0.3×	59	344
Candice Clarke United Kingdom	11	387 2.5×	25 0.2×	78 1.1×	24 0.4×	9 0.2×	24	497
Charlotte Laurent France	10	136 0.9×	27 0.2×	49 0.7×	58 1.1×	6 0.1×	27	327
Eleanor Anderson Williams United States	6	318 2.1×	78 0.6×	81 1.2×	33 0.6×	5 0.1×	6	438
Agathe Pardon France	9	96 0.6×	15 0.1×	35 0.5×	62 1.1×	25 0.5×	15	313
Dante Mário Langhi Brazil	12	65 0.4×	218 1.7×	49 0.7×	18 0.3×	52 1.1×	53	463
Keld Mikkelsen Homburg Denmark	7	302 2.0×	188 1.5×	14 0.2×	10 0.2×	48 1.0×	11	521

Countries citing papers authored by Emily Leven

Since Specialization

Citations

This map shows the geographic impact of Emily Leven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Leven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Leven more than expected).

Fields of papers citing papers by Emily Leven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Leven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Leven. The network helps show where Emily Leven may publish in the future.

Co-authorship network of co-authors of Emily Leven

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Leven. A scholar is included among the top collaborators of Emily Leven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Leven. Emily Leven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Leven, Emily, et al.. (2024). Novel biomarkers and strategies for HCC diagnosis and care. Clinical Liver Disease. 23(1). e0152–e0152. 3 indexed citations

Chan, Lili, Kusum S. Mathews, Deena R. Altman, et al.. (2021). Hyperglycemia is Associated With Increased Mortality in Critically Ill Patients With COVID-19. Endocrine Practice. 27(2). 95–100. 25 indexed citations

Chan, Lili, Kusum S. Mathews, Deena R. Altman, et al.. (2021). Hyperglycemia Is Associated With Increased Mortality in Critically Ill Patients With COVID-19. Journal of the Endocrine Society. 5(Supplement_1). A343–A344. 1 indexed citations

Wajnberg, Ania, Mayce Mansour, Emily Leven, et al.. (2020). Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study. The Lancet Microbe. 1(7). e283–e289. 83 indexed citations

Gudbrandsdottir, Sif, et al.. (2020). Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children. British Journal of Haematology. 189(2). e37–e40. 12 indexed citations

Mansour, Mayce, Emily Leven, Kimberly Muellers, et al.. (2020). Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City. Journal of General Internal Medicine. 35(8). 2485–2486. 48 indexed citations

Leven, Emily, Rachel A. Annunziato, Sarah R. Lieber, et al.. (2017). Medication adherence and rejection rates in older vs younger adult liver transplant recipients. Clinical Transplantation. 31(6). 17 indexed citations

Lieber, Sarah R., Emily Leven, Akhil Shenoy, et al.. (2017). Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.. Experimental and Clinical Transplantation. 16(5). 533–540. 14 indexed citations

Barrett, Thomas, Farrah Khan, Andrew M. Leader, et al.. (2017). Strengthening value-based medication management in a free clinic for the uninsured: Quality interventions aimed at reducing costs and enhancing adherence. BMJ Open Quality. 6(2). e000069–e000069. 7 indexed citations

10.

Leven, Emily, Patrick Maffucci, Hans D. Ochs, et al.. (2016). Hyper IgM Syndrome: a Report from the USIDNET Registry. Journal of Clinical Immunology. 36(5). 490–501. 68 indexed citations

11.

Gerrits, Anja J., Emily Leven, Andrew L. Frelinger, et al.. (2015). Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia. Blood. 126(11). 1367–1378. 58 indexed citations

12.

Ramaswamy, Kavitha, et al.. (2014). Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children. The Journal of Pediatrics. 165(3). 600–605.e4. 36 indexed citations

13.

Gerrits, Anja J., Emily Leven, Andrew L. Frelinger, et al.. (2013). Effects Of Eltrombopag On Thrombocytopenia, Platelet Function and Bleeding In Patients With Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia. Blood. 122(21). 3536–3536. 1 indexed citations

14.

Leven, Emily, Loan Hsieh, Kavitha Ramaswamy, et al.. (2013). Safe and Effective Use Of Romiplostim and Eltrombopag In Children With ITP. Blood. 122(21). 3541–3541. 3 indexed citations

15.

Leven, Emily, et al.. (2012). Successful Discontinuation of Eltrombopag Treatment in Patients with Chronic ITP. Blood. 120(21). 1085–1085. 19 indexed citations

16.

Leven, Emily, et al.. (2012). Cyclosporine-Romiplostim-IVIG Combination Therapy in Refractory ITP. Blood. 120(21). 1095–1095.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact